EFFECT OF ANTIHYPERTENSIVE TREATMENT ON THE INCREASED BETA(2)-ADRENOCEPTOR DENSITY IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引:10
作者
BONO, M [1 ]
CASES, A [1 ]
CALLS, J [1 ]
GAYA, J [1 ]
JIMENEZ, W [1 ]
CARRETERO, J [1 ]
RIVERA, F [1 ]
REVERT, L [1 ]
机构
[1] HOSP CLIN BARCELONA,SERV NEFROL,E-08036 BARCELONA,SPAIN
关键词
BETA(2)-ADRENOCEPTORS; EPINEPHRINE; CGP12177; ESSENTIAL HYPERTENSION; BISOPROLOL;
D O I
10.1016/0895-7061(95)00023-I
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The effect of different antihypertensive drugs on the increased surface beta(2)-adrenoceptor density in essential hypertension was evaluated to elucidate whether the possible effect of the treatment on these receptors was secondary to blood pressure decreases or a specific effect of the drugs. Thirty-nine untreated essential hypertensive patients and 28 normotensive control subjects were studied in basal conditions. Hypertensive patients were randomly assigned to three treatment groups: bisoprolol (10 mg/day, n = 15), enalapril (20 mg/day, n = 12), and verapamil SR (240 mg/day, n = 12), and were studied before and after 1 month of treatment. Plasma catecholamines were determined by a radioenzymatic assay. Surface beta(2)-adrenoceptors were measured in intact lymphocytes by radioligand binding assay using the hydrophilic ligand [H-3]-CGP12177. beta(2)-adrenoceptor density was increased in hypertensive patients (P < .01). After treatment, mean blood pressure decreased similarly in the three groups, while plasma catecholamines showed no significant changes in any group. beta(2)-adrenoceptor number decreased only in bisoprolol-treated patients (P < .05). Mean blood pressure decreases correlated with beta(2)-adrenoceptor decrements only in bisoprolol-treated patients (r = 0.65, P < .05). beta(2)-adrenoceptor density correlated with plasma epinephrine levels in the control group (r = -0.50, P < .01), but not in hypertensive patients before treatment. This correlation was also observed in hypertensive patients treated with bisoprolol (r -0.52, P < .05), but not in those treated with verapamil or enalapril. Our results suggest that bisoprolol treatment reduces the increased surface beta(2)-adrenoceptor density and restores its regulation by epinephrine in essential hypertension. This effect seems to be specific to beta-blockers, as these changes can be ascribed to neither blood pressure decreases nor to changes in plasma catecholamine levels.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 25 条
[1]  
Folkow, Physiological aspects of primary hypertension, Physiol Rev, 62, pp. 347-504, (1982)
[2]  
Goldstein, Plasma catecholamines in essential hypertension: an analytical review, Hypertension, 5, pp. 86-89, (1983)
[3]  
Brodde, Kresch, Ikezono, Et al., Human β-adrenoceptors: relation of myocardial and lymphocyte β-adrenoceptor density, Science, 231, pp. 1584-1585, (1986)
[4]  
Brodde, Seher, Nohlen, Et al., Correlation between myometrial and platelet α<sub>2</sub>-adrenoceptor density, European Journal of Pharmacology, 150, pp. 403-404, (1988)
[5]  
Ligget, Marker, Shah, Et al., Direct relationship between mononuclear leukocyte and lung β-ad-renergic receptors and apparent reciprocal regulation of extravascular but not intravascular α-and β-adrenergic receptors by the sympathochromaffin system in humans, Journal of Clinical Investigation, 82, pp. 48-56, (1988)
[6]  
Brodde, Stuka, Demuth, Et al., α- and β-adrenoceptors in circulating blood cells of essential hypertensive patients: increased receptor density and responsiveness, Clin Exp Hypertens, 7 A, pp. 1135-1150, (1985)
[7]  
Middeke, Remien, Holzgreve, The influence of sex age, blood pressure and physical stress on β<sub>2</sub>-adrenoceptor density of mononuclear cells, J Hypertens, 2, pp. 261-264, (1984)
[8]  
Bruschi, Orlandini, Pavarini, Et al., Lymphocyte β-adrenoceptor abnormality in primary hypertension, IRCS Med Sci, 12, pp. 461-462, (1984)
[9]  
Brodde, Daul, Wang, Et al., Dynamic exercise-induced increase in lymphocyte β<sub>2</sub>-adrenoceptors: abnormality in essential hypertension and its correction by antihypertensives, Clinical Pharmacology and Therapeutics, 41, pp. 371-379, (1986)
[10]  
Parfyonova, Korichnera, Suvorov, Et al., Characteristics of lymphocyte β-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise, Health Psychol, 7, pp. S33-S52, (1988)